EPH50 Characterizing the Prevalence of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Among Adults ≥65 Years of Age in the United States (US) Using Three Real-World Cohorts
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.879
https://www.valueinhealthjournal.com/article/S1098-3015(24)00994-X/fulltext
Section Title :
Section Order :
10324
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00994-X&doi=10.1016/j.jval.2024.03.879